[go: up one dir, main page]

EP2585090A4 - Traitement de la chéloïde - Google Patents

Traitement de la chéloïde

Info

Publication number
EP2585090A4
EP2585090A4 EP11800037.1A EP11800037A EP2585090A4 EP 2585090 A4 EP2585090 A4 EP 2585090A4 EP 11800037 A EP11800037 A EP 11800037A EP 2585090 A4 EP2585090 A4 EP 2585090A4
Authority
EP
European Patent Office
Prior art keywords
keloid treatment
keloid
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP11800037.1A
Other languages
German (de)
English (en)
Other versions
EP2585090A1 (fr
Inventor
Adebola O E Obayan
Sanjeev Singh
Brenda Collen Joyce Yuzdepski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADETHERAPEUTICS
Original Assignee
ADETHERAPEUTICS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADETHERAPEUTICS filed Critical ADETHERAPEUTICS
Publication of EP2585090A1 publication Critical patent/EP2585090A1/fr
Publication of EP2585090A4 publication Critical patent/EP2585090A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP11800037.1A 2010-06-28 2011-06-28 Traitement de la chéloïde Withdrawn EP2585090A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35905310P 2010-06-28 2010-06-28
PCT/CA2011/050396 WO2012000113A1 (fr) 2010-06-28 2011-06-28 Traitement de la chéloïde

Publications (2)

Publication Number Publication Date
EP2585090A1 EP2585090A1 (fr) 2013-05-01
EP2585090A4 true EP2585090A4 (fr) 2014-01-15

Family

ID=45401271

Family Applications (1)

Application Number Title Priority Date Filing Date
EP11800037.1A Withdrawn EP2585090A4 (fr) 2010-06-28 2011-06-28 Traitement de la chéloïde

Country Status (13)

Country Link
US (1) US20140005116A1 (fr)
EP (1) EP2585090A4 (fr)
JP (1) JP2013533867A (fr)
KR (1) KR20130089174A (fr)
CN (1) CN103002903B (fr)
AU (1) AU2011274224A1 (fr)
BR (1) BR112012033349A2 (fr)
CA (1) CA2804413A1 (fr)
CO (1) CO6680624A2 (fr)
MX (1) MX2013000107A (fr)
RU (1) RU2578426C2 (fr)
WO (1) WO2012000113A1 (fr)
ZA (1) ZA201209759B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11000545B2 (en) 2013-03-15 2021-05-11 Cda Research Group, Inc. Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza
US11318089B2 (en) 2013-03-15 2022-05-03 Cda Research Group, Inc. Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body
US10398733B2 (en) 2013-03-15 2019-09-03 Cda Research Group, Inc. Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body
US12318406B2 (en) 2013-03-15 2025-06-03 Cda Research Group, Inc. Methods of treatment using topical copper ion formulations
FR3004353B1 (fr) * 2013-04-10 2015-05-15 Fabre Pierre Dermo Cosmetique Association synergique de l'alanine-glutamine, l'acide hyaluronique et un extrait d'avoine, et son utilisation dans une composition destinee a la cicatrisation et la reparation des lesions cutanees
KR101800788B1 (ko) * 2017-03-31 2017-11-27 박영오 켈로이드 흉터 개선용 화장료 조성물
US10500318B1 (en) * 2018-07-03 2019-12-10 Temple Therapeutics BV Dosing regimens for treating hypoxia-associated tissue damage
US11193184B2 (en) 2019-02-22 2021-12-07 Cda Research Group, Inc. System for use in producing a metal ion suspension and process of using same
CN114767590B (zh) * 2022-04-20 2024-03-15 上海交通大学医学院附属第九人民医院 一种祛疤祛痘印美容液及其制备方法与应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087576A1 (fr) * 2001-04-30 2002-11-07 Arachnova Therapeutics Ltd. Traitement de cicatrisation et d'etats associes au moyen d'activateurs de ppar-gamma
WO2003037269A2 (fr) * 2001-10-31 2003-05-08 Abbott Laboratories Di-, tri,- et tetrapeptides ayant une activite antiangiogenique
WO2007016791A1 (fr) * 2005-08-11 2007-02-15 University Of Saskatchewan Réduire la formation d’adhérences post-opératoires par le biais de glutamine intrapéritonéale
WO2008098364A1 (fr) * 2007-02-15 2008-08-21 University Of Saskatchewan Réduction de la formation d'adhérences postopératoires avec de la glutamine intra-péritonéale

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5740409A (en) * 1980-08-22 1982-03-06 Mitsui Toatsu Chem Inc Remedy for disease caused by extraordinary propagation of collagen
US6149925A (en) * 1998-11-05 2000-11-21 Color Access, Inc. Topical compositions for enhancing glutathione production
AU7067200A (en) * 1999-08-23 2001-03-19 Organogenesis Inc. Skin care compositions and treatments
RU2234963C2 (ru) * 2002-09-16 2004-08-27 Сибирский государственный медицинский университет Способ лечения гипертрофических и келоидных кожных рубцов
US20050059610A1 (en) * 2003-09-12 2005-03-17 Paul Wischmeyer Glutamine for use in treating injury
RU2275216C1 (ru) * 2004-12-08 2006-04-27 Елена Григорьевна Арий Способ профилактики формирования патологических кожных рубцов
WO2007056068A2 (fr) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Formulations macrocycliques pour l'administration transmembranaire de medicament
CN100372522C (zh) * 2005-12-02 2008-03-05 何秋莎 护肤品

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002087576A1 (fr) * 2001-04-30 2002-11-07 Arachnova Therapeutics Ltd. Traitement de cicatrisation et d'etats associes au moyen d'activateurs de ppar-gamma
WO2003037269A2 (fr) * 2001-10-31 2003-05-08 Abbott Laboratories Di-, tri,- et tetrapeptides ayant une activite antiangiogenique
WO2007016791A1 (fr) * 2005-08-11 2007-02-15 University Of Saskatchewan Réduire la formation d’adhérences post-opératoires par le biais de glutamine intrapéritonéale
WO2008098364A1 (fr) * 2007-02-15 2008-08-21 University Of Saskatchewan Réduction de la formation d'adhérences postopératoires avec de la glutamine intra-péritonéale

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2012000113A1 *

Also Published As

Publication number Publication date
CO6680624A2 (es) 2013-05-31
ZA201209759B (en) 2014-03-26
CN103002903B (zh) 2015-04-22
BR112012033349A2 (pt) 2016-10-11
WO2012000113A1 (fr) 2012-01-05
HK1183626A1 (en) 2014-02-14
KR20130089174A (ko) 2013-08-09
AU2011274224A8 (en) 2014-09-18
CA2804413A1 (fr) 2012-01-05
EP2585090A1 (fr) 2013-05-01
US20140005116A1 (en) 2014-01-02
RU2578426C2 (ru) 2016-03-27
MX2013000107A (es) 2013-06-03
RU2013103507A (ru) 2014-08-10
AU2011274224A1 (en) 2013-01-17
CN103002903A (zh) 2013-03-27
JP2013533867A (ja) 2013-08-29

Similar Documents

Publication Publication Date Title
PL2652193T3 (pl) Obróbka
IL222481A0 (en) Combination therapy
EP2552323A4 (fr) Polythérapie
IL222702A0 (en) Incontinence treatment
EP2521569A4 (fr) Traitement combiné faisant appel au vb-201
ZA201209759B (en) Keloid treatment
IL222958A0 (en) Cancer treatment
IL220850A0 (en) Pigmentation-preventing or-ameliorating agent
GB201013573D0 (en) Treatment
EP2560679A4 (fr) Traitement de l'eczéma
EP2595594A4 (fr) Dispositif de massage
GB201005394D0 (en) Therapy
ZA201308117B (en) Avian-based treatment
GB201014097D0 (en) Treatment
EP2629766A4 (fr) Polythérapie
GB201102283D0 (en) Treatment
GB201021319D0 (en) Treatment
GB201102266D0 (en) Treatment
GB201102267D0 (en) Treatment
GB201102277D0 (en) Treatment
GB201102276D0 (en) Treatment
GB201102275D0 (en) Treatment
GB201102274D0 (en) Treatment
GB201102269D0 (en) Treatment
GB201102271D0 (en) Treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20130110

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131217

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 17/02 20060101ALI20131211BHEP

Ipc: A61K 9/10 20060101ALI20131211BHEP

Ipc: A61K 38/05 20060101AFI20131211BHEP

17Q First examination report despatched

Effective date: 20150529

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20151209